Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Feedback
    • Reprint Information
    • Subscriptions
  • ASN Kidney News
  • Other
    • ASN Publications
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • ASN Publications
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Feedback
    • Reprint Information
    • Subscriptions
  • ASN Kidney News
  • Visit ASN on Facebook
  • Follow CJASN on Twitter
  • CJASN RSS
  • Community Forum

About the Cover

June 2021; Volume 16,Issue 6

Looking for COVID information? All ASN Journal COVID articles are available in the COVID collection. All articles are free.​

Cover image

Cover image expansion

On the Cover

What is the diagnosis?

A 45-year-old male developed fever, weight loss, and persistent cough of 3 months’ duration. His sputum was positive for Mycobacterium tuberculosis, and he was started on antitubercular treatment with four drugs: isoniazid, rifampicin, ethambutol, and pyrazinamide. His baseline kidney and liver function tests, before initiating antituberculosis therapy, were normal. Two weeks later, he presented with edema, breathlessness, oliguria with kidney failure requiring dialysis, and serum creatinine of 7.2 mg/dl. His laboratory tests were significant for hemoglobin with a level of 8.3 g/dl, bilirubin of 3.2 mg/dl with mild transaminitis, and serum lactate dehydrogenase of 750 U/L. Antitubercular treatment was withheld, and kidney biopsy was performed.

Image Description: The biopsy demonstrated histological features of acute tubular injury including loss of brush borders, flattening (simplification) of the tubular epithelial cells, and cell drop-off, and dissolution of the cytoplasm and in many of the tubular epithelial cells. Bright ly eosinophilic granular-to-globular pigmented tubular casts were seen in some of the tubules. These casts were different from red cell casts as there was no identifiable residual red cell morphology (red cell ghosts) within them. There was mild interstitial edema, but no inflammatory cells were observed in the in terstitium. No in terstitial fibrosis or tubular atrophy was seen. Glomeruli and blood vessels appeared normal with no evidence of microangiopathy. The casts did not show light chain restriction on immunofluorescence test. They were negative for myoglobin immunohistochemical stain but strongly positive for hemoglobin immunohistochemical stain, thus establishing the diagnosis of hemoglobin cast nephropathy.

Teaching Points: Rifampicin is routinely used in multidrug treatment regimens for tuberculosis, nontuberculous mycobacterial infections, and leprosy. AKI is not a common complication of this drug. The most frequent biopsy findings in rifampicin-associated AKI are acute interstitial nephritis and acute tubular injury. Rifampicin-associated AKI develops as a result of type II or III hypersensitivity reaction. Antirifampicin antibodies are known to develop. These may cross-react with blood group I antigen on red blood cells leading to complementmediated hemolysis. Heme pigment is toxic to the tubular epithelial cells. It can precipitate with Tamm–Horsfall protein to form pigmented tubular casts. Hemoglobin cast nephropathy should be suspected if a patient on rifampicin therapy develops AKI. The accurate diagnosis requires a kidney biopsy with immunostain for hemoglobin.

After five sessions of hemodialysis, urine output improved and reached nadir creatinine of 1.4 mg/dl after 6 weeks. Antitubercular treatment was restarted sequentially without rifampicin, and the patient tolerated it well.

(Text and images provided by Anila Abraham Kurien, Department of Pathology, Renopath Center for Renal and Urological Pathology, Chennai, India; Myvizhiselvi Murugan, Department of Nephrology, Madras Medical College, Chennai, India; and Gopalakrishnan Natarajan, Department of Nephrology, Madras Medical College, Chennai, India.)

Back to top
PreviousNext

In this issue

Clinical Journal of the American Society of Nephrology: 16 (6)
Clinical Journal of the American Society of Nephrology
Vol. 16, Issue 6
June 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Sign up for alerts
View Selected Citations (0)

Podcast

Subscribe to podcast
Download MP3

Jump to

  • Patient Voice
  • Editorials
  • Original Articles
    • Acute Kidney Injury and ICU Nephrology
    • Chronic Kidney Disease
    • Cystic Kidney Disease
    • Maintenance Dialysis
    • Transplantation
  • Research Letters
  • Genomics of Kidney Disease
  • Kidney Case Conference: Nephrology Quiz and Questionnaire
  • Perspectives
  • Feature
  • Review
  • Most Read
Loading
  • Drug-Induced Acute Kidney Injury
  • Low-Flow Acute Kidney Injury
  • The Intensivist's Perspective of Shock, Volume Management, and Hemodynamic Monitoring
  • Sepsis Management for the Nephrologist
  • Classification of Uremic Toxins and Their Role in Kidney Failure
More...

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Trainee of the Year
  • Author Resources
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • CJASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About CJASN
  • CJASN Email Alerts
  • CJASN Key Impact Information
  • CJASN Podcasts
  • CJASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Subscribe to ASN Journals
  • Wolters Kluwer Partnership

© 2022 American Society of Nephrology

Print ISSN - 1555-9041 Online ISSN - 1555-905X

Powered by HighWire